Diagnostic criteria for thrombocytopenia

The diagnostic criteria for thrombocytopenia are mainly based on a comprehensive evaluation of a series of clinical manifestations, laboratory test results, and other relevant factors. The following is an interpretation of the diagnostic criteria for thrombocytopenia:

1. Clinical manifestations

1. Bleeding symptoms: Patients with thrombocytopenia often present with symptoms such as continued bleeding after injury, purple-red plaques or petechiae on the skin, nosebleeds, gum bleeding, and menorrhagia. These symptoms are caused by abnormal coagulation due to a reduced number of platelets.

2. Splenomegaly: Although most patients with thrombocytopenia have no or only mild spleen enlargement, splenomegaly may also be one of the clinical manifestations of certain diseases that cause thrombocytopenia (such as hypersplenism).

2. Laboratory test results

1. Routine blood examination: Routine blood examination is the most direct method to diagnose thrombocytopenia. Under normal circumstances, the platelet count should be between 100*10^9/L. When the platelet count is less than 100*10^9/L, it is the accepted diagnostic standard.

2. Bone marrow examination: Bone marrow is the place where platelets are produced. In the case of thrombocytopenia, a bone marrow examination can help doctors evaluate platelet production and whether other blood system abnormalities are present. In bone marrow examination, if the number of megakaryocytes is increased or normal but there is a maturation disorder, it may be a sign of thrombocytopenia.

3. Other blood tests: including complete blood count (CBC), blood smear test, etc. These tests can help doctors evaluate the status of red and white blood cells and whether other blood system disorders are present.

3. Rule out other diseases

When diagnosing thrombocytopenia, it is also necessary to exclude other diseases that may cause thrombocytopenia, such as autoimmune diseases (such as lupus erythematosus, Sjogren's syndrome, etc.), infections, drug side effects, chronic diseases, etc. This requires a series of tests and evaluations to determine the specific cause of the thrombocytopenia.

The diagnosis of thrombocytopenia cannot be determined by a single indicator, and the same is true for treatment. Currently, common treatment drugs include Romiplostim, Eltrombopag and Avatrombopag.